Sanofi reported €43.6B of revenue over the trailing twelve months, +16% on the year before. 10 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: €43.6B (to FY2025). Net Income: €7.81B, trailing twelve months to FY2025. Free Cash Flow: €8.93B, trailing twelve months to FY2025. Op Margin: 15%, trailing twelve months to FY2025.

SNYSanofi

HealthcareUSD

$45.44

$41.3152 weeks$49.59

SNY as reported

Sanofi reported €43.6B of revenue over the trailing twelve months, +16% on the year before. 10 reported series are charted on this page, each one as filed.

€43.6B

Revenue, trailing twelve months · to FY2025 · +16% against the twelve months before

Net Income: €7.81B
Net Income · +26% year on year · trailing twelve months to FY2025
Free Cash Flow: €8.93B
Free Cash Flow · −1.00% year on year · trailing twelve months to FY2025
Op Margin: 15%
Op Margin · trailing twelve months to FY2025

Every series Ryufin has for SNY, trailing twelve months
Series	Latest	Year on year	As of
Revenue	€43.6B	+16%	FY2025
Net Income	€7.81B	+26%	FY2025
EPS	€6.37	+29%	FY2025
Gross Margin	77%	n/a	FY2025
Op Margin	15%	n/a	FY2025
Net Margin	18%	n/a	FY2025
ROE	11%	n/a	FY2025
ROA	6.2%	n/a	FY2025
ROIC	6.1%	n/a	FY2025
Free Cash Flow	€8.93B	−1.00%	FY2025